The following table presents the classification of these restructuring, associated, and other costs in the condensed consolidated statements of income for the MiniMed restructuring activities:


	Three months ended
(in millions)	July 31, 2026

Selling, general, and administrative expenses	$	8
Restructuring charges, net	58
Total restructuring, associated, and other costs	$	67

The following table provides a reconciliation of the beginning and ending restructuring liability balances related to the MiniMed restructuring activities for the three months ended July 31, 2026:


(in millions)	Employee Termination Benefits		Associated and Other Costs		Total
April 24, 2026	$	119	$	—	$	119
Charges	62		5		67
Cash payments	(88)		(4)		(92)

July 31, 2026	$	93	$	1	$	93

The following table presents the classification of these restructuring, associated, and other costs in the condensed consolidated statements of income for the other restructuring activities:


	Three months ended
(in millions)	July 31, 2026		July 25, 2025
Cost of products sold	$	8	$	16
Selling, general, and administrative expenses	2		5
Restructuring charges, net	13		45
Total restructuring, associated, and other costs	$	23	$	67

The following table provides a reconciliation of the beginning and ending restructuring liability balances relating to the other restructuring activities:


(in millions)	Employee Termination Benefits		Associated and Other Costs		Total
April 24, 2026	$	11	$	44	$	56
Charges	13		2		15
Cash payments	(9)		(19)		(28)

July 31, 2026	$	15	$	27	$	42